Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12

References

• Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, et al. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017. Lancet Public Health. 2020;5:e551–e67.
   PubMed Web of Science ®Google Scholar
• GBD 2016 Motor Neuron Disease Collaborators. Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1083–97.
   PubMed Web of Science ®Google Scholar
• Alonso A, Logroscino G, Jick SS, Hernan MA. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol. 2009;16:745–51.
   PubMed Web of Science ®Google Scholar
• Rehm J, Üstün TB, Saxena S, Nelson CB, Chatterji S, Ivis F, et al. On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. Int J Method Psychiatr Res. 1999;8:110–22.
   Google Scholar
• Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, WHO/NIH Joint Project, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88:815–23.
   PubMed Web of Science ®Google Scholar
• Federici S, Bracalenti M, Meloni F, Luciano JV. World Health Organization disability assessment schedule 2.0: An international systematic review. Disabil Rehabil. 2017;39:2347–80.
   PubMed Web of Science ®Google Scholar
• Midhage R, Hermansson L, Söderberg P, Tungström S, Nordenskjöld A, Svanborg C, et al. Psychometric evaluation of the Swedish self-rated 36-item version of WHODAS 2.0 for use in psychiatric populations—using classical test theory. Nord J Psychiatr. 2021;75:494–501.
   PubMed Web of Science ®Google Scholar
• Yuliana S, Muslih M, Sim J, Vidyanti AN, Brahmadhi A, Tsai HT. Development and validation of the World Health Organization disability Assessment Schedule 2.0 (WHODAS 2.0) Indonesian version in stroke survivors. Disabil Rehabil. 2021. Online ahead of print.
   PubMed Web of Science ®Google Scholar
• Saltychev M, Katajapuu N, Bärlund E, Laimi K. Psychometric properties of 12-item self-administered World Health Organization disability assessment schedule 2.0 (WHODAS 2.0) among general population and people with non-acute physical causes of disability—systematic review. Disabil Rehabil. 2021;43:789–94.
   PubMed Web of Science ®Google Scholar
• Saltychev M, Mattie R, McCormick Z, Laimi K. Confirmatory factor analysis of 12-Item World Health Organization Disability Assessment Schedule in patients with musculoskeletal pain conditions. Clin Rehabil. 2017;31:702–9.
   PubMed Web of Science ®Google Scholar
• MacLeod MA, Tremblay PF, Graham K, Bernards S, Rehm J, Wells S. Psychometric properties and a latent class analysis of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in a pooled dataset of community samples. Int J Methods Psychiatr Res. 2016;25:243–54.
   PubMed Web of Science ®Google Scholar
• Vaganian L, Bussmann S, Boecker M, Kusch M, Labouvie H, Gerlach AL, et al. An item analysis according to the Rasch model of the German 12-item WHO Disability Assessment Schedule (WHODAS 2.0). Qual Life Res. 2021;30:2929–38.
   PubMed Web of Science ®Google Scholar
• Snell DL, Siegert RJ, Silverberg ND. Rasch analysis of the World Health Organization Disability Assessment Schedule 2.0 in a mild traumatic brain injury sample. Brain Inj. 2020;34:610–8.
   PubMed Web of Science ®Google Scholar
• Tarvonen-Schroder S, Kaljonen A, Laimi K. Disability in amyotrophic lateral sclerosis compared with traumatic brain injury using the World Health Organization Disability Assessment Schedule 2.0 and the international classification of functioning minimal generic set. Int J Rehabil Res. 2018;41:224–9.
   PubMed Web of Science ®Google Scholar
• Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12:368–80.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Üstün T, Kostanjsek N, Chatterji S, Rehm J. Measuring Health and Disability Manual for WHO Disability Assessment Schedule. Geneva: World Health Organization; 2010.
   Google Scholar
• Rasch G. Probabilistic Models for Some Intelligence and Attainment Tests. Chicago: University of Chicago Press; 1960.
   Google Scholar
• Wright BD, Linacre JM. Observations are always ordinal; measurements, however, must be interval. Arch Phys Med Rehabil. 1989;70:857–60.
   PubMed Web of Science ®Google Scholar
• Fischer G, Molenaar I. Rasch Models: Foundations, Recent Developments, and Applications. New York: Springer; 1995.
   Google Scholar
• Ornbjerg L, Christensen K, Tennant A, Hetland M. Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias. Scand J Rheumatol. 2020;49:1–7.
   PubMed Web of Science ®Google Scholar
• Mallinson T. Rasch analysis of repeated measures. Rasch Measurement Transactions. 2011;25:1317.
   Google Scholar
• Hagell P, Westergren A. Sample size and statistical conclusions from tests of fit to the Rasch model according to the Rasch unidimensional measurement model (Rumm) program in health outcome measurement. J Appl Meas. 2016;17:416–31.
   PubMedGoogle Scholar
• Müller M. Item fit statistics for Rasch analysis: can we trust them? J Stat Distrib App. 2020;7:5.
   Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.
   PubMed Web of Science ®Google Scholar
• Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018;27:7–22.
   PubMed Web of Science ®Google Scholar
• Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82–90.
   PubMed Web of Science ®Google Scholar
• Jones BL, Nagin DS. A note on a Stata plugin for estimating group-based trajectory models. Sociolo Methods Res. 2013;42:608–13.
   Web of Science ®Google Scholar
• Mori M, Krumholz HM, Allore HG. Using latent class analysis to identify hidden clinical phenotypes. JAMA 2020;324:700–1.
   PubMed Web of Science ®Google Scholar
• StataCorp. Stata Statistical Software. Release 15th ed. College Station, TX: StataCorp LLC; 2017.
   Google Scholar
• Sennfält S, Kläppe U, Thams S, Samuelsson K, Press R, Fang F, et al. The path to diagnosis in ALS: delay, referrals, alternate diagnoses, and clinical progression. Amyotroph Lateral Scler Frontotemporal Degener. 2022;1–9.
   Web of Science ®Google Scholar
• Eisen A, Kiernan M, Mitsumoto H, Swash M. Amyotrophic lateral sclerosis: a long preclinical period? J Neurol Neurosurg Psychiatry. 2014;85:1232–8.
   PubMed Web of Science ®Google Scholar
• Benatar M, Turner MR, Wuu J. Defining pre-symptomatic amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:303–9.
   PubMed Web of Science ®Google Scholar
• Pawlukowska W, Baumert B, Gołąb-Janowska M, Meller A, Machowska-Sempruch K, Wełnicka A, et al. Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis. BMC Neurol. 2019;19:241.
   PubMed Web of Science ®Google Scholar
• Shibuya K, Misawa S, Sekiguchi Y, Beppu M, Amino H, Suichi T, et al. Prodromal muscle cramps predict rapid motor functional decline in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90:242–3.
   PubMed Web of Science ®Google Scholar